In HER2-expressing breast tumor treated with ADCs, pre-clinical mouse model studies revealed that the expression of PD-1 in CD8+ T cells and of PD-L1 on tumor cells/tumor-associated macrophages is upregulated and tumor-infiltrating lymphocytes were also revealed to be increased compared with in the vehicle control. The gene discussed is ERBB2; the disease is breast neoplasm.